Bonesupport Holding AB (publ) (STO:BONEX)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 13.51B |
| Revenue (ttm) | 1.17B |
| Net Income (ttm) | 142.15M |
| Shares Out | 66.76M |
| EPS (ttm) | 0.66 |
| PE Ratio | 95.06 |
| Forward PE | 44.51 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 400,179 |
| Average Volume | 312,512 |
| Open | 197.00 |
| Previous Close | 202.40 |
| Day's Range | 191.10 - 202.00 |
| 52-Week Range | 165.00 - 402.00 |
| Beta | 0.39 |
| RSI | 56.10 |
| Earnings Date | Feb 24, 2026 |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t... [Read more]
Financial Performance
In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.
Financial StatementsNews
Bonesupport Holding AB (publ) (BOEUF) Q3 2025 Earnings Call Transcript
Bonesupport Holding AB (publ) (BOEUF) Q3 2025 Earnings Call Transcript